
Dual CDKN2A/MTAP loss compared to CDKN2A loss alone and …
Jun 2, 2022 · We examined combined CDKN2A/MTAP deletion vs. CDKN2A deletion/mutation alone as predictors of poor ICI response. Methods: We curated clinical data for cancer patients (pts) treated with ICI at Dana-Farber Cancer Institute through 6/2021, who …
MTAP protein status is highly concordant with CDKN2A …
CDKN2A homozygous deletion (HD), identified in 30.3% of MIBCs, and MTAP loss, found in 28.8% of MIBCs, were both significantly associated with the luminal‐URO subtype, FGFR3 mutations, and normal/wildtype p53 IHC (P < 0.05).
Enzyme-mediated depletion of methylthioadenosine restores T …
Sep 28, 2023 · Chromosomal region 9p21 containing tumor suppressors CDKN2A/B and methylthioadenosine phosphorylase (MTAP) is one of the most frequent genetic deletions in cancer. 9p21 loss is correlated with reduced tumor-infiltrating lymphocytes (TILs) and resistance to immune checkpoint inhibitor (ICI) therapy.
MTAP immunohistochemistry is an accurate and reproducible
Jun 23, 2019 · MTAP immunohistochemistry is a reliable surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant mesothelioma. Interobserver agreement is excellent for interpretation...
CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet …
Co-deletion of the CDKN2A and methylthioadenosine phosphorylase (MTAP) genes has been researched extensively and discovered to be a highly specific characteristic of MPM. Most studies have used FISH to detect the deletion of CDKN2A and IHC for MTAP as a surrogate for this.
Deletions of CDKN2A and MTAP Detected by Copy-Number …
In this study, CDKN2A-MTAP co-deletion was associated with loss of both p16 and MTAP protein expression in all cases with homozygous deletion and in the majority of cases with heterozygous deletion of CDKN2A-MTAP.
Correlation of MTAP Immunohistochemistry With CDKN2A Status …
Jan 29, 2022 · Methylthioadenosine phosphorylase (MTAP) immunohistochemistry is a promising surrogate marker for CDKN2A homozygous deletion in different cancers but has not been examined in meningiomas.
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer ... - PubMed
Feb 8, 2021 · The methylthioadenosine phosphorylase (MTAP) gene is located adjacent to the cyclin-dependent kinase inhibitor 2A (CDKN2A) tumor-suppressor gene and is co-deleted with CDKN2A in approximately 15% of all cancers.
CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet …
Nov 13, 2020 · Co-deletion of the CDKN2A and methylthioadenosine phosphorylase (MTAP) genes has been researched extensively and discovered to be a highly specific characteristic of MPM. Most studies have used FISH to detect the deletion of CDKN2A and IHC for MTAP as a surrogate for this.
Disordered methionine metabolism in MTAP/CDKN2A-deleted ... - Science
Feb 11, 2016 · 5-Methylthioadenosine phosphorylase (MTAP) is a key enzyme in the methionine salvage pathway. The MTAP gene is frequently deleted in human cancers because of its chromosomal proximity to the tumor suppressor gene CDKN2A.